abs239.txt	immune	checkpoint	blockade		which	blocks	the	regulatory	pathways	that	express	onimmune	cells	to	improve	antitumor	immunological	responses	is	becoming	one	of	themost	promising	approaches	for	therapy	this	has	achievedimportant	clinical	advancement	and	provided	a	new	opportunity	against	varietyof	cancers	however	limitations	inhibitors	application	includingthe	risk	autoimmune	disease	low	objective	response	rates	high	cost	still	largely	affect	their	broad	applications	in	patients	therefore	it	isdesirable	seek	effective	delivery	methods	further	enhance	therapeuticefficacy	reduce	drawbacks	brief	reviewsummarizes	strategies	increase	immunity	including	local	andtargeted	combination	differentcheckpoint	or	with	other	therapeutic	treatments
